Activity trackers with walking programs increase activity levels in early-stage breast cancer patients
Activity Trackers Help Breast Cancer Patients Maintain Exercise Levels
This randomized controlled trial of 320 patients receiving aromatase inhibitor therapy found that a 24-week walking program with an activity…
A new study shows that using a wearable activity tracker helps women with breast cancer maintain consistent exercise habits over two years.
Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes
Many common medicines might change gut bacteria and affect bone strength in older adults
This narrative review examines the association between medications such as glucocorticoids and aromatase inhibitors and gut microbiota alter…
Some drugs like antidepressants and seizure medicines can alter gut bacteria. Scientists are still studying if these changes hurt bones or c…
CDK4/6i plus AI or fulvestrant shows similar clinical benefit in HR+ HER2- MBC
Two drugs linked to longer survival than palbociclib in breast cancer
This retrospective single-center analysis of 341 patients with HR+/HER2− MBC found that palbociclib, abemaciclib, and dalpiciclib combined w…
In a real-world analysis, two CDK4/6 inhibitors showed longer survival times than palbociclib for metastatic breast cancer patients.